Literature DB >> 9795259

Physico-chemical and antigenic properties of tetanus and diphtheria toxoids and steps towards improved stability.

P Johansen1, H P Merkle, B Gander.   

Abstract

Physico-chemical, antigenic and immunogenic properties may be altered during microencapsulation of antigens and their release from poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Here, the physico-chemical, conformational and antigenic stability of tetanus and diphtheria toxoids was studied in aqueous solutions stressed by elevated temperature and the presence of lactic and glycolic acids. Further, the stabilising effect of albumin was investigated. The analytical tools used were fluorimetry, circular dichroism spectroscopy, turbidimetry, electrophoresis and ELISA. Elevated temperatures altered the physico-chemical and antigenic properties of the toxoids to a greater extent than the acids (50 mM) did. Substantial unfolding and chemical changes of tryptophan were observed upon 1-4 weeks of incubation at 60 degreesC. At 4 degreesC, only minor conformational changes were observed, even in the presence of the acids. Furthermore, 40% of the tetanus toxoid antigenicity was lost after 7 days at 37 degreesC. This loss increased in the presence of the acids. At 60 degreesC, the antigenicity had completely vanished. Very importantly, 0.5% albumin preserved the tetanus antigenicity over 6 weeks' incubation at 37 degreesC, regardless of the presence of glycolic acid. This qualifies albumin as potential stabilising additive for toxoid loaded poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795259     DOI: 10.1016/s0304-4165(98)00097-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

Review 1.  Protein instability in poly(lactic-co-glycolic acid) microparticles.

Authors:  M van de Weert; W E Hennink; W Jiskoot
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Accelerated stability studies for moisture-induced aggregation of tetanus toxoid.

Authors:  Nishant Kumar Jain; Ipsita Roy
Journal:  Pharm Res       Date:  2010-11-12       Impact factor: 4.200

3.  Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.

Authors:  P Johansen; Y Men; R Audran; G Corradin; H P Merkle; B Gander
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

4.  On technological and immunological benefits of multivalent single-injection microsphere vaccines.

Authors:  Gérard Boehm; Marisa Peyre; Dorothea Sesardic; Rachel J Huskisson; Fatme Mawas; Alexandra Douglas; Dorothy Xing; Hans P Merkle; Bruno Gander; Pål Johansen
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 5.  Injectable controlled release depots for large molecules.

Authors:  Steven P Schwendeman; Ronak B Shah; Brittany A Bailey; Anna S Schwendeman
Journal:  J Control Release       Date:  2014-06-12       Impact factor: 9.776

6.  Biophysical comparison of diphtheria and tetanus toxins with the formaldehyde-detoxified toxoids, the main components of diphtheria and tetanus vaccines.

Authors:  Husam Alsarraf; Emil Dedic; Morten J Bjerrum; Ole Østergaard; Max Per Kristensen; Jesper W Petersen; René Jørgensen
Journal:  Virulence       Date:  2017-05-16       Impact factor: 5.882

7.  Stabilization of tetanus toxoid encapsulated in PLGA microspheres.

Authors:  Wenlei Jiang; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2008-08-19       Impact factor: 4.939

8.  Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines.

Authors:  Kay Lockyer; Fang Gao; Jeremy P Derrick; Barbara Bolgiano
Journal:  Vaccine       Date:  2015-01-29       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.